135 related articles for article (PubMed ID: 28507750)
1. Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.
Appleby RN; Bajor A; Gillberg PG; Graffner H; Simrén M; Ung KA; Walters J
United European Gastroenterol J; 2017 Apr; 5(3):380-388. PubMed ID: 28507750
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.
Pattni SS; Brydon WG; Dew T; Walters JR
Clin Transl Gastroenterol; 2012 Jul; 3(7):e18. PubMed ID: 23238290
[TBL] [Abstract][Full Text] [Related]
4. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
Walters JR
Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):426-34. PubMed ID: 24662279
[TBL] [Abstract][Full Text] [Related]
5. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
[TBL] [Abstract][Full Text] [Related]
6. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
Walters JR; Johnston IM; Nolan JD; Vassie C; Pruzanski ME; Shapiro DA
Aliment Pharmacol Ther; 2015 Jan; 41(1):54-64. PubMed ID: 25329562
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Serum and Distal Ileum Fibroblast Growth Factor19 in Bile Acid Diarrhoea Patients.
Chang C; Jiang J; Sun R; Wang S; Chen H
Dig Dis Sci; 2022 Mar; 67(3):872-879. PubMed ID: 34041651
[TBL] [Abstract][Full Text] [Related]
8. Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy.
Orekoya O; McLaughlin J; Leitao E; Johns W; Lal S; Paine P
Clin Med (Lond); 2015 Jun; 15(3):252-7. PubMed ID: 26031975
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.
Borup C; Syversen C; Bouchelouche P; Damgaard M; Graff J; Rumessen JJ; Munck LK
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1399-402. PubMed ID: 26426834
[TBL] [Abstract][Full Text] [Related]
10. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Walters JR; Tasleem AM; Omer OS; Brydon WG; Dew T; le Roux CW
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
[TBL] [Abstract][Full Text] [Related]
11. Managing bile acid diarrhoea.
Walters JR; Pattni SS
Therap Adv Gastroenterol; 2010 Nov; 3(6):349-57. PubMed ID: 21180614
[TBL] [Abstract][Full Text] [Related]
12. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.
Bajor A; Törnblom H; Rudling M; Ung KA; Simrén M
Gut; 2015 Jan; 64(1):84-92. PubMed ID: 24727487
[TBL] [Abstract][Full Text] [Related]
13. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
[TBL] [Abstract][Full Text] [Related]
14. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
Borup C; Wildt S; Rumessen JJ; Bouchelouche PN; Graff J; Damgaard M; McQuitty C; Rainteau D; Munck LK
Aliment Pharmacol Ther; 2017 Jun; 45(11):1433-1442. PubMed ID: 28378364
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
Valentin N; Camilleri M; Altayar O; Vijayvargiya P; Acosta A; Nelson AD; Murad MH
Gut; 2016 Dec; 65(12):1951-1959. PubMed ID: 26347530
[TBL] [Abstract][Full Text] [Related]
16. Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
Johnston IM; Nolan JD; Pattni SS; Appleby RN; Zhang JH; Kennie SL; Madhan GK; Jameie-Oskooei S; Pathmasrirengam S; Lin J; Hong A; Dixon PH; Williamson C; Walters JR
Am J Gastroenterol; 2016 Mar; 111(3):423-32. PubMed ID: 26856750
[TBL] [Abstract][Full Text] [Related]
17. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and Clinical Management of Bile Acid Diarrhea.
Marasco G; Cremon C; Barbaro MR; Falangone F; Montanari D; Capuani F; Mastel G; Stanghellini V; Barbara G
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683489
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
Liu T; Ma M; Li K; Tan W; Yu H; Wang L
J Clin Gastroenterol; 2023 May-Jun 01; 57(5):451-458. PubMed ID: 36867517
[TBL] [Abstract][Full Text] [Related]
20. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
